Jacqueline G Parchem1,2, Teresa N Sparks1,3, Kristen Gosnell4, Mary E Norton1,3. 1. Division of Maternal-Fetal Medicine, Department of Obstetrics, Gynecology & Reproductive Sciences, University of California, San Francisco, CA, USA. 2. Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Baylor College of Medicine, Houston, TX, USA. 3. Division of Medical Genetics, Department of Pediatrics, University of California, San Francisco, CA, USA. 4. Fetal Treatment Center, Benioff Children's Hospital, University of California, San Francisco, CA, USA.
Abstract
OBJECTIVE: The objective of this study was to determine the association of copy number variants (CNV) with perinatal outcomes among fetuses with sonographic abnormalities. METHODS: This was a retrospective cohort study of anomalous fetuses evaluated at a single fetal center, who underwent chromosomal microarray (CMA) testing. Pathogenic CNV or variants of uncertain significance were classified as abnormal. The primary outcome of perinatal death was compared among fetuses with normal vs abnormal CMA. Secondary outcomes included preterm birth, small for gestational age birth weight, and death prior to discharge. The odds ratio (OR) of perinatal death was determined, adjusting for potential confounders. RESULTS: Of 280 fetuses, 60 (21.4%) had abnormal CMA results-21 (35.0%) were classified as pathogenic, 39 (65.0%) were variants of uncertain significance. Among 212 (75.7%) continuing pregnancies, abnormal CMA was not associated with increased odds of perinatal death (adjusted OR 0.81, 95% CI 0.34-1.93), after adjustment for the presence of hydrops and specific anomalies. The overall frequency of perinatal death was 21.2%. No differences in secondary outcomes were observed. CONCLUSIONS: Abnormal CMA was not associated with increased odds of perinatal death in this cohort. Fetal CNV are common among fetal center patients; such fetuses are at high risk of perinatal death irrespective of CMA results.
OBJECTIVE: The objective of this study was to determine the association of copy number variants (CNV) with perinatal outcomes among fetuses with sonographic abnormalities. METHODS: This was a retrospective cohort study of anomalous fetuses evaluated at a single fetal center, who underwent chromosomal microarray (CMA) testing. Pathogenic CNV or variants of uncertain significance were classified as abnormal. The primary outcome of perinatal death was compared among fetuses with normal vs abnormal CMA. Secondary outcomes included preterm birth, small for gestational age birth weight, and death prior to discharge. The odds ratio (OR) of perinatal death was determined, adjusting for potential confounders. RESULTS: Of 280 fetuses, 60 (21.4%) had abnormal CMA results-21 (35.0%) were classified as pathogenic, 39 (65.0%) were variants of uncertain significance. Among 212 (75.7%) continuing pregnancies, abnormal CMA was not associated with increased odds of perinatal death (adjusted OR 0.81, 95% CI 0.34-1.93), after adjustment for the presence of hydrops and specific anomalies. The overall frequency of perinatal death was 21.2%. No differences in secondary outcomes were observed. CONCLUSIONS: Abnormal CMA was not associated with increased odds of perinatal death in this cohort. Fetal CNV are common among fetal center patients; such fetuses are at high risk of perinatal death irrespective of CMA results.
Authors: Fleurisca J Korteweg; Katelijne Bouman; Jan Jaap H M Erwich; Albertus Timmer; Nic J G M Veeger; Joke M Ravisé; Thomas H Nijman; Jozien P Holm Journal: Obstet Gynecol Date: 2008-04 Impact factor: 7.661
Authors: Jennifer C Donnelly; Lawrence D Platt; Andrei Rebarber; Julia Zachary; William A Grobman; Ronald J Wapner Journal: Obstet Gynecol Date: 2014-07 Impact factor: 7.661
Authors: Teri A Manolio; Douglas M Fowler; Lea M Starita; Melissa A Haendel; Daniel G MacArthur; Leslie G Biesecker; Elizabeth Worthey; Rex L Chisholm; Eric D Green; Howard J Jacob; Howard L McLeod; Dan Roden; Laura Lyman Rodriguez; Marc S Williams; Gregory M Cooper; Nancy J Cox; Gail E Herman; Stephen Kingsmore; Cecilia Lo; Cathleen Lutz; Calum A MacRae; Robert L Nussbaum; Jose M Ordovas; Erin M Ramos; Peter N Robinson; Wendy S Rubinstein; Christine Seidman; Barbara E Stranger; Haoyi Wang; Monte Westerfield; Carol Bult Journal: Cell Date: 2017-03-23 Impact factor: 41.582
Authors: David T Miller; Margaret P Adam; Swaroop Aradhya; Leslie G Biesecker; Arthur R Brothman; Nigel P Carter; Deanna M Church; John A Crolla; Evan E Eichler; Charles J Epstein; W Andrew Faucett; Lars Feuk; Jan M Friedman; Ada Hamosh; Laird Jackson; Erin B Kaminsky; Klaas Kok; Ian D Krantz; Robert M Kuhn; Charles Lee; James M Ostell; Carla Rosenberg; Stephen W Scherer; Nancy B Spinner; Dimitri J Stavropoulos; James H Tepperberg; Erik C Thorland; Joris R Vermeesch; Darrel J Waggoner; Michael S Watson; Christa Lese Martin; David H Ledbetter Journal: Am J Hum Genet Date: 2010-05-14 Impact factor: 11.025
Authors: Ronald J Wapner; Christa Lese Martin; Brynn Levy; Blake C Ballif; Christine M Eng; Julia M Zachary; Melissa Savage; Lawrence D Platt; Daniel Saltzman; William A Grobman; Susan Klugman; Thomas Scholl; Joe Leigh Simpson; Kimberly McCall; Vimla S Aggarwal; Brian Bunke; Odelia Nahum; Ankita Patel; Allen N Lamb; Elizabeth A Thom; Arthur L Beaudet; David H Ledbetter; Lisa G Shaffer; Laird Jackson Journal: N Engl J Med Date: 2012-12-06 Impact factor: 91.245
Authors: Lisa G Shaffer; Mindy P Dabell; Allan J Fisher; Justine Coppinger; Anne M Bandholz; Jay W Ellison; J Britt Ravnan; Beth S Torchia; Blake C Ballif; Jill A Rosenfeld Journal: Prenat Diagn Date: 2012-08-02 Impact factor: 3.050
Authors: Anne H Mardy; Naseem Rangwala; Yessenia Hernandez-Cruz; Kristen A Gosnell; Juan M Gonzalez; Mary E Norton; Teresa N Sparks Journal: Prenat Diagn Date: 2020-02-11 Impact factor: 3.050